Shares of ConvaTec Group Plc (OTCMKTS:CNVVY) have received an average rating of “Hold” from the seven research firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and two have assigned a buy recommendation to the company.
CNVVY has been the subject of a number of recent analyst reports. Morgan Stanley reiterated an “equal weight” rating on shares of ConvaTec Group in a report on Wednesday, December 9th. JPMorgan Chase & Co. reissued a “neutral” rating on shares of ConvaTec Group in a research report on Monday, March 8th. Finally, Barclays restated an “overweight” rating on shares of ConvaTec Group in a research note on Tuesday, January 19th.
Shares of OTCMKTS:CNVVY traded down $0.18 during trading on Friday, hitting $11.34. 500 shares of the company were exchanged, compared to its average volume of 1,540. ConvaTec Group has a 1-year low of $8.42 and a 1-year high of $11.53. The business’s 50 day moving average is $10.71 and its 200-day moving average is $10.47.
About ConvaTec Group
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.
Further Reading: What causes a recession?
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.